74 related articles for article (PubMed ID: 23127611)
1. Sequencing of t(2;7) translocations reveals a consistent breakpoint linking CDK6 to the IGK locus in indolent B-cell neoplasia.
Parker EP; Siebert R; Oo TH; Schneider D; Hayette S; Wang C
J Mol Diagn; 2013 Jan; 15(1):101-9. PubMed ID: 23127611
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis.
Parker E; Macdonald JR; Wang C
Cancer Genet; 2011 May; 204(5):260-4. PubMed ID: 21665179
[TBL] [Abstract][Full Text] [Related]
3. Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies.
Douet-Guilbert N; Tous C; Le Flahec G; Bovo C; Le Bris MJ; Basinko A; Morel F; De Braekeleer M
Cancer Genet; 2014 Mar; 207(3):83-6. PubMed ID: 24726269
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the t(2;8)/MYC-IGK translocation in high-grade lymphoma/leukemia by long-distance inverse PCR.
Kroenlein H; Schwartz S; Reinhardt R; Rieder H; Molkentin M; Gökbuget N; Hoelzer D; Thiel E; Burmeister T
Genes Chromosomes Cancer; 2012 Mar; 51(3):290-9. PubMed ID: 22120970
[TBL] [Abstract][Full Text] [Related]
6. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
[TBL] [Abstract][Full Text] [Related]
7. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci.
Martín-Subero JI; Harder L; Gesk S; Schlegelberger B; Grote W; Martinez-Climent JA; Dyer MJ; Novo FJ; Calasanz MJ; Siebert R
Int J Cancer; 2002 Mar; 98(3):470-4. PubMed ID: 11920602
[TBL] [Abstract][Full Text] [Related]
8. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia.
Brito-Babapulle V; Gruszka-Westwood AM; Platt G; Andersen CL; Elnenaei MO; Matutes E; Wotherspoon AC; Weston-Smith SG; Catovsky D
Haematologica; 2002 Apr; 87(4):357-62. PubMed ID: 11940479
[TBL] [Abstract][Full Text] [Related]
9. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
Sinclair P; Harrison CJ; Jarosová M; Foroni L
Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
[TBL] [Abstract][Full Text] [Related]
10. A novel sequence-based approach to localize translocation breakpoints identifies the molecular basis of a t(4;22).
Nimmakayalu MA; Gotter AL; Shaikh TH; Emanuel BS
Hum Mol Genet; 2003 Nov; 12(21):2817-25. PubMed ID: 12952865
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.
Chen D; Law ME; Theis JD; Gamez JD; Caron LB; Vrana JA; Dogan A
Am J Surg Pathol; 2009 May; 33(5):720-9. PubMed ID: 19145199
[TBL] [Abstract][Full Text] [Related]
12. Variant t(2;11)(p11.2;q13) without IGK involvement in a case of mantle cell lymphoma.
Woroniecka R; Grygalewicz B; Pienkowska-Grela B; Rymkiewicz G; Konecki R; Swoboda P; Janik P
Cancer Genet Cytogenet; 2007 Jun; 175(2):154-8. PubMed ID: 17556072
[TBL] [Abstract][Full Text] [Related]
13. Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.
Kobayashi S; Taki T; Chinen Y; Tsutsumi Y; Ohshiro M; Kobayashi T; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
Genes Chromosomes Cancer; 2011 Apr; 50(4):207-16. PubMed ID: 21319257
[TBL] [Abstract][Full Text] [Related]
14. Variant t(14;18) in malignant lymphoma: a report of seven cases.
Bentley G; Palutke M; Mohamed AN
Cancer Genet Cytogenet; 2005 Feb; 157(1):12-7. PubMed ID: 15676141
[TBL] [Abstract][Full Text] [Related]
15. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
[TBL] [Abstract][Full Text] [Related]
16. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2.
Einerson RR; Law ME; Blair HE; Kurtin PJ; McClure RF; Ketterling RP; Flynn HC; Dogan A; Remstein ED
Leukemia; 2006 Oct; 20(10):1790-9. PubMed ID: 16888615
[TBL] [Abstract][Full Text] [Related]
17. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma.
Ye BH; Rao PH; Chaganti RS; Dalla-Favera R
Cancer Res; 1993 Jun; 53(12):2732-5. PubMed ID: 8504412
[TBL] [Abstract][Full Text] [Related]
18. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
19. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
